The total return over the past 12 months is -66.24% vs. +16.94% for the S&P 500. So far it's up -71.79% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (66.24%) | (45.77%) | (46.34%) | N/A | N/A | N/A |
| Total Return CAGR | (66.24%) | (45.77%) | (46.34%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Estrella Immunopharma, Inc. (ESLA)
| Year | Start price | End price | ESLA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.56 | $0.44 | (71.79%) | +14.51% | (86.30%) |
| 2025 | $1.20 | $1.56 | +30.00% | +17.72% | +12.28% |
| 2024 | $1.11 | $1.20 | +8.11% | +24.89% | (16.78%) |
| 2023 | $10.29 | $1.11 | (89.21%) | +26.19% | (115.40%) |
| 2022 | $9.91 | $10.29 | +3.83% | (18.17%) | +22.00% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
